Chédiak–Higashi syndrome
Chédiak-Higashi syndrome is a rare autosomal recessive congenital immunodeficiency mainly characterized by a condition called oculo-cutaneous albinism. The affected subjects have light-colored hair, vision problems, blood clotting (coagulation) abnormalities and in adulthood varying neurologic disor...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Mazandaran University of Medical Sciences
2013-05-01
|
Series: | Journal of Pediatrics Review |
Subjects: | |
Online Access: | http://jpediatricsreview.com/en/articles/2512.html |
id |
doaj-28ca026024444dce8058945c1ad6edab |
---|---|
record_format |
Article |
spelling |
doaj-28ca026024444dce8058945c1ad6edab2020-11-25T00:28:50ZengMazandaran University of Medical SciencesJournal of Pediatrics Review2322-43982322-44012013-05-011211Chédiak–Higashi syndromeJavad Ghaffari0Seyed Abdolrahim Rezaee 1Mohammad Gharagozlou2Molecular and Cell Biology Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, IranDepartment of Immunology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranDepartment of Immunology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, IranChédiak-Higashi syndrome is a rare autosomal recessive congenital immunodeficiency mainly characterized by a condition called oculo-cutaneous albinism. The affected subjects have light-colored hair, vision problems, blood clotting (coagulation) abnormalities and in adulthood varying neurologic disorders. Recurrent infections, particularly viral infection with other disorders in childhood are usually life threatening. It has demonstrated mutations throughout the CHS1/LYST gene. The nature of the mutation can be a predictor of the severity of the disease. The current therapeutic options are: Antibiotics, chemotherapy and bone marrow transplantation. This review will discuss the clinical and molecular aspects of this syndrome for better understanding of the factors that may cause abnormalities.http://jpediatricsreview.com/en/articles/2512.htmlChediak-Higashi syndrome; Albinism; Immunodeficiency |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Javad Ghaffari Seyed Abdolrahim Rezaee Mohammad Gharagozlou |
spellingShingle |
Javad Ghaffari Seyed Abdolrahim Rezaee Mohammad Gharagozlou Chédiak–Higashi syndrome Journal of Pediatrics Review Chediak-Higashi syndrome; Albinism; Immunodeficiency |
author_facet |
Javad Ghaffari Seyed Abdolrahim Rezaee Mohammad Gharagozlou |
author_sort |
Javad Ghaffari |
title |
Chédiak–Higashi syndrome |
title_short |
Chédiak–Higashi syndrome |
title_full |
Chédiak–Higashi syndrome |
title_fullStr |
Chédiak–Higashi syndrome |
title_full_unstemmed |
Chédiak–Higashi syndrome |
title_sort |
chédiak–higashi syndrome |
publisher |
Mazandaran University of Medical Sciences |
series |
Journal of Pediatrics Review |
issn |
2322-4398 2322-4401 |
publishDate |
2013-05-01 |
description |
Chédiak-Higashi syndrome is a rare autosomal recessive congenital immunodeficiency mainly characterized by a condition called oculo-cutaneous albinism. The affected subjects have light-colored hair, vision problems, blood clotting (coagulation) abnormalities and in adulthood varying neurologic disorders. Recurrent infections, particularly viral infection with other disorders in childhood are usually life threatening.
It has demonstrated mutations throughout the CHS1/LYST gene. The nature of the mutation can be a predictor of the severity of the disease.
The current therapeutic options are: Antibiotics, chemotherapy and bone marrow transplantation.
This review will discuss the clinical and molecular aspects of this syndrome for better understanding of the factors that may cause abnormalities. |
topic |
Chediak-Higashi syndrome; Albinism; Immunodeficiency |
url |
http://jpediatricsreview.com/en/articles/2512.html |
work_keys_str_mv |
AT javadghaffari chediakhigashisyndrome AT seyedabdolrahimrezaee chediakhigashisyndrome AT mohammadgharagozlou chediakhigashisyndrome |
_version_ |
1725334121922691072 |